In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
The closing price of NewAmsterdam Pharma Company NV (NASDAQ: NAMS) was $22.88 for the day, down -2.10% from the previous closing price of $23.37. In other words, the price has decreased by -$2.10 from its previous closing price. On the day, 1.82 million shares were traded.
Ratios:
Our analysis of NAMS’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 8.08 and its Current Ratio is at 8.08. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on December 30, 2024, initiated with a Buy rating and assigned the stock a target price of $48.
On March 14, 2024, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $35.Scotiabank initiated its Sector Outperform rating on March 14, 2024, with a $35 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 04 ’25 when Topper James N bought 4,005 shares for $21.02 per share. The transaction valued at 84,203 led to the insider holds 3,012,434 shares of the business.
Kooij Louise Frederika sold 150,000 shares of NAMS for $3,055,500 on Mar 04 ’25. The Chief Accounting Officer now owns 15,000 shares after completing the transaction at $20.37 per share. On Mar 04 ’25, another insider, Kooij Louise Frederika, who serves as the Officer of the company, bought 150,000 shares for $20.27 each.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 55.15 while its Price-to-Book (P/B) ratio in mrq is 3.26.
Stock Price History:
Over the past 52 weeks, NAMS has reached a high of $27.29, while it has fallen to a 52-week low of $15.19. The 50-Day Moving Average of the stock is 2.73%, while the 200-Day Moving Average is calculated to be 15.21%.
Shares Statistics:
A total of 108.06M shares are outstanding, with a floating share count of 56.66M. Insiders hold about 48.41% of the company’s shares, while institutions hold 47.85% stake in the company.
